Related Experiment Video

Updated: Aug 15, 2026

Biosensor for Detection of Antibiotic Resistant Staphylococcus Bacteria
14:04

Biosensor for Detection of Antibiotic Resistant Staphylococcus Bacteria

Published on: May 8, 2013

Antibiotic resistance in Staphylococcus aureus and its relevance in therapy

Abhijit M Bal1, Ian M Gould

  • 1Department of Medical Microbiology, Aberdeen Royal Infirmary, Foresterhill, Aberdeen AB25 2ZN, Scotland. a.bal@abdn.ac.uk

Expert Opinion on Pharmacotherapy
|October 13, 2005
PubMed

Insights

Staphylococcus aureus infections are common, with increasing resistance to antibiotics like penicillin and methicillin-resistant S. aureus (MRSA) posing treatment challenges. This review covers therapeutic options for resistant strains, including novel strategies.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Pharmacology

Background:

  • Staphylococcus aureus is a significant pathogen, with penicillin resistance affecting most strains.
  • Methicillin-resistant S. aureus (MRSA) resists all beta-lactam antibiotics, necessitating alternative treatments.
  • Emerging resistance to glycopeptides (vancomycin) in MRSA strains creates difficult-to-treat infections.

Purpose of the Study:

  • To review current and novel therapeutic strategies for infections caused by MRSA.
  • To discuss treatment options for glycopeptide-intermediate S. aureus and vancomycin-resistant S. aureus.
  • To explore emerging therapeutic approaches including immunotherapy and vaccines.

Main Methods:

  • Literature review of therapeutic options for S. aureus infections.
  • Analysis of treatment strategies for antibiotic-resistant strains.
  • Discussion of novel therapeutic modalities.

Main Results:

  • Beta-lactamase stable penicillins are standard for S. aureus infections.
  • Glycopeptides are effective against most MRSA but resistance is increasing.
  • Vancomycin-resistant S. aureus presents significant treatment challenges.

Conclusions:

  • Effective treatment of S. aureus infections, particularly MRSA and vancomycin-resistant strains, requires careful consideration of antibiotic resistance patterns.
  • Novel therapeutic strategies are crucial for managing infections caused by multidrug-resistant S. aureus.
  • Immunotherapy and vaccines represent promising future directions for combating S. aureus infections.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Antibiotic Selection00:57

Antibiotic Selection

Overview
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...